PetMed Express (PETS)
(Delayed Data from NSDQ)
$3.28 USD
-0.01 (-0.30%)
Updated Sep 9, 2024 04:00 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Balance Sheet
Fiscal Year End for PetMed Express, Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 55 | 104 | 111 | 119 | 104 |
Receivables | 3 | 2 | 2 | 3 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 29 | 19 | 32 | 34 | 18 |
Other Current Assets | 7 | 7 | 6 | 5 | 4 |
Total Current Assets | 94 | 131 | 151 | 161 | 129 |
Net Property & Equipment | 27 | 26 | 24 | 25 | 25 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 5 | 1 | 0 | 0 | 0 |
Intangibles | 43 | 6 | 1 | 1 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 170 | 164 | 176 | 188 | 155 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 37 | 25 | 28 | 40 | 20 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 7 | 11 | 6 | 5 | 4 |
Income Taxes Payable | 25 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 72 | 37 | 33 | 45 | 24 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 1 | 1 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 4 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 73 | 40 | 34 | 46 | 25 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 25 | 18 | 12 | 7 | 4 |
Retained Earnings | 72 | 105 | 131 | 134 | 126 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 97 | 124 | 142 | 141 | 130 |
Total Liabilities & Shareholder's Equity | 170 | 164 | 176 | 188 | 155 |
Total Common Equity | 97 | 124 | 142 | 141 | 130 |
Shares Outstanding | 21.10 | 21.00 | 20.90 | 20.20 | 20.10 |
Book Value Per Share | 4.58 | 5.89 | 6.80 | 6.99 | 6.47 |
Fiscal Year End for PetMed Express, Inc falls in the month of March.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 46 | 55 | 49 | 53 | 62 |
Receivables | 2 | 3 | 2 | 2 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 26 | 29 | 35 | 19 | 32 |
Other Current Assets | 4 | 7 | 10 | 11 | 10 |
Total Current Assets | 78 | 94 | 96 | 86 | 106 |
Net Property & Equipment | 26 | 27 | 27 | 27 | 27 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 5 | 5 | 6 | 5 | 7 |
Intangibles | 43 | 43 | 44 | 40 | 38 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 153 | 170 | 173 | 159 | 181 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 24 | 37 | 39 | 25 | 40 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 5 | 7 | 6 | 11 | 13 |
Income Taxes Payable | 26 | 25 | 24 | 0 | 0 |
Other Current Liabilities | 2 | 3 | 3 | 4 | 3 |
Total Current Liabilities | 58 | 72 | 72 | 41 | 57 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 4 | 4 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 59 | 73 | 73 | 46 | 62 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 17 | 25 | 23 | 22 | 20 |
Retained Earnings | 77 | 72 | 77 | 92 | 98 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 94 | 97 | 100 | 114 | 118 |
Total Liabilities & Shareholder's Equity | 153 | 170 | 173 | 159 | 181 |
Total Common Equity | 94 | 97 | 100 | 114 | 118 |
Shares Outstanding | 20.60 | 21.10 | 21.10 | 21.10 | 21.10 |
Book Value Per Share | 4.54 | 4.58 | 4.74 | 5.39 | 5.61 |